4.05 USD
↘ 0.17 (4.03%)AT CLOSE (03:59 PM EDT)
ImageneBio, Inc. Common Stock
IMANASDAQ • USD
4.09
↗ 0.04 (0.99%)
POST MARKET (AS OF 04:01 PM EDT)
Post Market
AS OF 04:01 PM EDT
4.09
↗ 0.04 (0.99%)
Market: CLOSED
Shares of ImageneBio, Inc. Common Stock (IMA) are trading at $3.98. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, IMA appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$4.15
High?$4.42
Low?$3.88
Prev. Close?$4.22
Volume?32.9K
Avg. Volume?15.4K
VWAP?$4.00
Rel. Volume?2.13x
Bid / Ask
Bid?$3.85 × 800
Ask?$4.50 × 1.0K
Spread?$0.65
Midpoint?$4.18
Valuation & Ratios
Market Cap?46.0M
Shares Out?11.4M
Float?9.4M
Float %?83.2%
P/E Ratio?N/A
P/B Ratio?0.32
EPS?-$4.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Employees
18
Market Cap
47.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2025-07-28
Address
12526 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: 857-343-8292
SAN DIEGO, CA 92130
Phone: 857-343-8292
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?4
Momentum?50
Short Sent.?68
Piotroski F-Score?0/9Weak
Altman Z-Score?0.24Distress
Confidence?29%Very Low
Short InterestModerate
Short % of Float?0.65%Low
Short Interest?61.3K
Days to Cover?4.2
Free Float9.4M
Avg Daily Volume14.6K
Settlement Date2026-10-15
Financial Health
Current Ratio?21.47Strong
Quick Ratio?21.47Strong
Cash Ratio?14.40Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.32CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.8CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-37.5%WEAK▾
S&P3
ROA?-35.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-57733000
Enterprise Value?$-48703603
Fundamentals ratios updated end of day